Centers for Disease Control (henceforth “CDC”), Pneumocystis pneumonia—Los Angeles, Morbidity and Mortality Weekly Report (henceforth “MMWR”) 1981, 30: 250–52.
2.
BenensonAS, ed., Control of communicable diseases in man, 14th ed., Washington, D.C.: American Public Health Association, 1985: 295–96.
3.
CDC, Kaposi's sarcoma and pneumocystis pneumonia among homosexual men—New York City and California, MMWR1981, 30: 305–8; CDC, Follow-up on Kaposi's sarcoma and pneumocystis pneumonia, MMWR1981, 30: 409–10.
4.
Benenson, supra note 2, pp. 2–5CDC, Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States, MMWR1985, 34:373–75.
5.
CDC, Weekly Surveillance Report—United States AIDS Program, November 3, 1986.
6.
CDC, Update: Acquired immunodeficiency syndrome—United States, MMWR1986, 35: 17–21; CDC, Weekly Surveillance Report—United States AIDS Program, October 6, 1986.
7.
CDC, Weekly Surveillance Report—United States AIDS Program, October 6, 1986.
8.
CDC, Acquired immunodeficiency syndrome (AIDS) among blacks and Hispanics—United States, MMWR1986, 35:655–66.
9.
GoedertJJBlattnerWA, The epidemiology of AIDS and related conditions, in DeVitaVTJr.HellmanSRosenbergSA, eds., AIDS: Etiology, diagnosis, treatment and prevention, Philadelphia: Lippincott, 1985: 1–30; JaffeHW, AIDS in a cohort of homosexual men: A six year follow-up study, Annals of Internal Medicine1985, 103: 210–14.
10.
WinkelsteinW, Reduction in AIDS virus transmission: Seroconversion in San Francisco, 1982–85, paper presented at the International Conference on AIDS (ICA), Paris, June 1986.
11.
GoedertJJ, Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members, Science1986, 231: 992–95; MarmorM, HTLV-III seropositivity and its relationship to disease in a prospective study of homosexual men, paper presented at the International Conference on Acquired Immunodeficiency Syndrome (IC), Atlanta, Georgia, April 1985; StevensCE, Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City, Journal of the American Medical Association1986, 255: 2167–72.
12.
DetelsR, Predictions of AIDS in young homosexual men, paper presented at ICA, Paris, 1986.
13.
Goedert, supra note 11.
14.
MayerKH, Natural history of HTLV-III/LAV infection in asymptomatic male homosexuals in Boston, paper presented at ICA, Paris, 1986.
15.
RinaldoC, Association of HTLV-III with risk factors for AIDS in gay men from a low incidence area, paper presented at IC, Atlanta, 1985.
16.
WeissS, Screening test for HTLV-III (AIDS) agent antibodies, Journal of the American Medical Association1985, 253: 221–25; CohenH, Behavioral risk factors for HTLV-III/LAV seropositivity among intravenous drug abusers, paper presented at IC, Atlanta, 1985; WeissSH, Risk for HTLV-III exposure and AIDS among parenteral drug abusers in New Jersey, paper presented at IC, Atlanta, 1985.
17.
CravenDE, Prevalence to human T-cell leukemia (lymphotropic) virus, type III (HTLV-III) in parenteral abusers (PDA's) attending a methadone clinic, paper presented at IC, Atlanta, 1985.
18.
SpiraTJ, HTLV-III/LAV antibodies in intravenous drugs (IV) abusers—a comparison of high and low risk areas for AIDS, paper presented at IC, Atlanta, 1985.
19.
RagniMV, Prevalence and seroconversion rate of human T-lymphotropic retrovirus (HTLV-III) antibody in patients with hemophilia, paper presented at IC, Atlanta, 1985; JasonJ, Lymphadenopathy-associated virus antibody in persons with hemophilia, paper presented at IC, Atlanta, 1985; EgsterMEGoedertJJSargadhavanMG, Early natural history of HTLV-III antibodies in persons with hemophilia, paper presented at IC, Atlanta, 1985.
20.
CDC, Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody prevalence in U.S. military recruit applicants, MMWR1986, 35: 421–24.
21.
SchorrJB, Prevalence of HTLV-III antibody in American blood donors (Letter), New England Journal of Medicine1985, 313: 384–85.
22.
Public Health Service plan for the prevention and control of AIDS and the AIDS virus, Report of the Koolfont Planning Conference, June 4–6, 1986.
23.
Wong-StaalFGalloRC, Human T-lymphotropic retroviruses, Nature1985, 317: 395–403; ZaguryD, Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS, Science1986, 231: 850–53.
24.
SodroskiJ, A second post-transcriptional transactivator gene required for HTLV-III replication, Nature1986, 321: 412–17.
25.
GondaMA, Sequence hemology and morphologic similarity of HTLV-III and Visna virus, a pathogenic lentivirus, Science1986, 227: 173–77.
26.
HahnBH, Genetic variation in HTLV-III/LAV over time in patients with AIDS or risk for AIDS, Science1986, 232: 1548–53.
27.
Zagury, supra note 23.
28.
BurnetMWhitePO, Natural history of infectious disease, 4th ed., Cambridge: Cambridge University Press, 1972.
29.
CooperDA, Acute AIDS retrovirus infection: Definition of a clinical illness associated with seroconversion, Lancet1985, i: 537–40.
30.
CarneCA, Acute encephalopathy coincident with seroconversion for anti-HTLV-III, Lancet1985, ii: 1206–8; GoudsmitJ, Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS-related complex, British Medical Journal1986, 292: 1231–34.
31.
MayerKH, HTLV-III viremia in asymptomatic, high risk, seronegative homosexual men, Annals of Internal Medicine1986, 104: 194–96.
32.
LuiK-J, A model-based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome, Proceedings of the National Academy of Science USA1986, 83: 3051–55.
33.
MelbyeM, Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: Development of immunologic and clinical abnormalities, Annals of Internal Medicine1986, 104: 496–500.
34.
CDC, 1986, Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections, MMWR1986, 35: 334–39.
35.
Melbye, supra note 33.
36.
StevensCE, Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City, Journal of the American Medical Association1986, 255: 2167–72.
37.
Goedert, supra note 11.
38.
HunterDJDeGruttolaV, Estimation of risk of outcome of HTLV-III infection, Lancet1986, i: 677–78.
39.
VogtMW, Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS, Lancet1986, i: 525–27; GroopmanJE, HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk of AIDS, Science1984, 226: 447–49.
40.
ArchibaldDW, Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk of AIDS, Blood1986, 67: 831–34.
41.
DetelsR, Relation between sexual practices and T-cell subsets in homosexually active men, Lancet1983, i: 609–11; GoedertJJ, Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men, Lancet1984, ii: 711–16; MayerKH, Association of human T-lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy, American Journal of Medicine1986, 80: 357–63.
42.
CDC, Heterosexual transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus, MMWK1985, 35: 561–63; LedermanMM, Transmission of the acquired immunodeficiency syndrome through heterosexual activity, Annals of Internal Medicine1986, 104: 115–16.
43.
New AIDS studies focus on its spread, New York Times, October 1, 1986, B6.
44.
StewartGJ, Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor, Lancet1985, ii: 581–84.
45.
AsjoB, Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection, Lancet1986, ii: 660–62.
46.
CurranJW, Acquired immunodeficiency syndrome (AIDS) associated with transfusions, New England Journal of Medicine1984, 310: 69–75.
47.
LaPointeN, Transplacental transmission of HTLV-III virus, New England Journal of Medicine1985, 312: 1325.
48.
ParksWPScottGB, Pediatric AIDS: A disease spectrum causally associated with HTLV-III infection, Cancer Research (Supp) 1985, 45: 4659S–61S.
49.
ZieglarJB, Postnatal transmission of AIDS-associated retrovirus from mother to infant, Lancet1985, i: 896–98.
50.
HirschMS, Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III), New England Journal of Medicine1985, 312: 1–4; GeddesAM, Risk of AIDS to health care workers, British Medical Journal1986, 292: 711–12; McCrayE, Occupational risk of the acquired immunodeficiency syndrome among health care workers, New England Journal of Medicine1986, 314: 1127–32; KleinRSPhelanJFriedlandGH, Prevalence of antibodies (Abs) to HTLV-III/LAV among dental professionals (DP), paper presented at ICA, Paris, 1986; GerberdingJL, Risk to dentists from exposure to patients infected with AIDS virus (AV), paper presented at ICA, Paris, 1986.
51.
Anonymous, Needlestick transmission of HTLV-III from a patient infected in Africa, Lancet1984, ii: 1376–77; StricofRLMorseDL, HTLV-III/LAV seroconversion following a deep intramuscular needlestick injury, New England Journal of Medicine1986, 314: 1115; Neisson-VernantC, Needlestick HIV seroconversion in a nurse, Lancet1986, ii: 814.
52.
GerberdingJL, Transmission of hepatitis B without transmission of AIDS by accidental needlestick, New England Journal of Medicine1985, 312: 56.
53.
KaplanJE, Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome, Pediatric Infectious Disease1985, 4: 468–71; ConnorE, Lack of transmission of HTLV-III from children with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC) to household contacts (HC), paper presented at ICA, Paris, 1986; RogersMFWhiteCRSandersR, Can children transmit HTLV-III/LAV infection?, paper presented at the ICA, Paris, 1986.
54.
WahnV, Horizontal transmission of HIV infection between two siblings, Lancet1986, ii: 694.
55.
FriedlandGH, Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis, New England Journal of Medicine1986, 314: 344–49.
56.
LawrenceDN, HTLV-III/LAV antibody status of spouses and household contacts assisting in home infusion of hemophilia patients, Blood1985, 66: 703–5; JasonJM, HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia, Journal of the American Medical Association1986, 255: 212–15.